Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...

The Miami Grand Prix didn’t just bring Formula 1 back after an extended break—it reshaped the early narrative of the 2026 season. Between a third straight win for Kimi Antonelli, a resurgent McLaren, ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...